Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Inebilizumab for Treatment of IgG4-Related Disease.
Stone JH, Khosroshahi A, Zhang W, Della Torre E, Okazaki K, Tanaka Y, Löhr JM, Schleinitz N, Dong L, Umehara H, Lanzillotta M, Wallace ZS, Ebbo M, Webster GJ, Martinez Valle F, Nayar MK, Perugino CA, Rebours V, Dong X, Wu Y, Li Q, Rampal N, Cimbora D, Culver EL; MITIGATE Trial Investigators. Stone JH, et al. Among authors: culver el. N Engl J Med. 2024 Nov 14. doi: 10.1056/NEJMoa2409712. Online ahead of print. N Engl J Med. 2024. PMID: 39541094
An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index.
Wallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart PA, Karadag O, Kawa S, Kawano M, Kim MH, Lanzillotta M, Matsui S, Okazaki K, Ryu JH, Saeki T, Schleinitz N, Tanasa P, Umehara H, Webster G, Zhang W, Stone JH. Wallace ZS, et al. Among authors: culver el. Arthritis Care Res (Hoboken). 2018 Nov;70(11):1671-1678. doi: 10.1002/acr.23543. Arthritis Care Res (Hoboken). 2018. PMID: 29457382 Free PMC article.
The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease.
Wallace ZS, Naden RP, Chari S, Choi H, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Kubota K, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Sekiguchi H, Schleinitz N, Stone JR, Takahashi N, Umehara H, Webster G, Zen Y, Stone JH; American College of Rheumatology/European League Against Rheumatism IgG4-Related Disease Classification Criteria Working Group. Wallace ZS, et al. Arthritis Rheumatol. 2020 Jan;72(1):7-19. doi: 10.1002/art.41120. Epub 2019 Dec 2. Arthritis Rheumatol. 2020. PMID: 31793250
The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease.
Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH; Members of the ACR/EULAR IgG4-RD Classification Criteria Working Group. Wallace ZS, et al. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561. Epub 2019 Dec 3. Ann Rheum Dis. 2020. PMID: 31796497 Review.
Emerging therapy options for IgG4-related disease.
Lanzillotta M, Fernàndez-Codina A, Culver E, Ebbo M, Martinez-Valle F, Schleinitz N, Della-Torre E. Lanzillotta M, et al. Expert Rev Clin Immunol. 2021 May;17(5):471-483. doi: 10.1080/1744666X.2021.1902310. Epub 2021 Mar 25. Expert Rev Clin Immunol. 2021. PMID: 33689549 Review.
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: a European multi-centre study.
Ramirez GA, Lanzillotta M, Ebbo M, Fernandez-Codina A, Mancuso G, Orozco-Galvez O, Dagna L, Schleinitz N, Martínez-Valle F, Culver EL, Della-Torre E. Ramirez GA, et al. Among authors: culver el. Rheumatology (Oxford). 2022 May 5;61(5):e109-e111. doi: 10.1093/rheumatology/keab930. Rheumatology (Oxford). 2022. PMID: 34919665 Free PMC article. No abstract available.
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners.
Iaccarino L, Talarico R, Bozzalla-Cassione E, Burmester GR, Culver EL, Doria A, Ebbo M, van Hagen PM, Hachulla E, van Laar JAM, Lanzillotta M, Martinez-Valle F, Montecucco C, Monti S, Nalli C, Schleinitz N, Tincani A, Della-Torre E, Alexander T. Iaccarino L, et al. Among authors: culver el. Clin Exp Rheumatol. 2022 May;40 Suppl 134(5):71-80. doi: 10.55563/clinexprheumatol/qq9qup. Epub 2022 Mar 1. Clin Exp Rheumatol. 2022. PMID: 35238758 Free article. Review.
Development of an algorithm for IgG4-related disease management.
Orozco-Gálvez O, Fernández-Codina A, Lanzillotta M, Ebbo M, Schleinitz N, Culver EL, Rebours V, D'Cruz DP, Della-Torre E, Martínez-Valle F. Orozco-Gálvez O, et al. Among authors: culver el. Autoimmun Rev. 2023 Mar;22(3):103273. doi: 10.1016/j.autrev.2023.103273. Epub 2023 Jan 20. Autoimmun Rev. 2023. PMID: 36682575 Review.
76 results